Search
Haemonetics Corp
HAEAdd to Watchlist
119.930USD
-4.180-3.37%
Close 11-06 16:00（ET）
5.46BMarket Cap
58.16P/E TTM
After-hours 19:00 (ET)119.930USD+0.145+0.12%
After-hours 19:00 (ET)Haemonetics Corp (HAE) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Haemonetics Corp in the past month.
Buy
5 Strong Buy
4 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
142.778USD+19.33%
HAE Analyst Recommendation Trends
In the current month, HAE has received 4 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. HAE average Analyst price target in the last month is 142.778.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
5
5
4
4
4
3
3
3
4
4
4
4
4
4
4
4
2
2
3
3
3
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
11
11
11
11
HAE Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Financial Forecasting
Based on analysts' estimates, HAE EPS is projected to reach 1.359 in FY2027Q3, following reported EPS of 1.018 in FY2027Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
FY2027Q4
Forecast
1.27
1.08
1.29
1.36
1.52
Actual
-0.44
0.73
1.02
--
--
Surprise
-134.27%
-32.42%
-21.18%
--
--
FAQs
What is Haemonetics Corp's expected revenue for the next quarter?
Haemonetics Corp's expected revenue is 357.79M.
What is Haemonetics Corp's price target?
Analysts forecast that Haemonetics Corp's price target is USD 142.78, with the highest forecast at USD 230.00 and the lowest forecast at USD 115.00.
How have Haemonetics CorpHAE's recent earnings per share performed?
The market expectation was USD 1.02, while Haemonetics CorpHAE's earnings per share (EPS) for the previous quarter was USD 0.73. EPS for the next quarter is expected at USD 1.36.
What is the analyst rating for Haemonetics Corp?
Based on the ratings of Haemonetics Corp's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.